IoT and Big Data Are Working Together To Develop Better Vaccines in the Covid-19 Era

Big data and the internet of things (IoT) are playing a major role in the development and global distribution of modern vaccines. 

The rapid development of the COVID-19 vaccines is having a profound effect on the world.

Omicron is spreading rapidly. Big data and IoT could be key in new breakthroughs such as new oral therapeutics.

The Covid-19 pandemic revealed the urgent need for the acceleration of vaccine development worldwide.

What's The Difference Between the Internet of Things and Big Data?

Source: i-scoop 

The Internet of Things (IoT) is a set of gadgets, devices, wearables and machines that can connect to each other and communicate data with each other and that have been powered by consumer products. It is generated by machines, but its value increases according to the data they collect.

Source: Daqifi 

On the other hand, Big Data is generated by humans. In a context where not only humans interact with technology to create data, but also machines interact with each other, it is thanks to the human-created Big Data that the elements of the IoT are able to act intelligently and become more sophisticated.

The Role of IoT and Big Data During the Covid-19 Pandemic 

Source: Research Gate

Pharmaceutical companies are harnessing the power of big data and the internet of things to monitor vaccines. The Pfizer and Moderna COVID-19 vaccines rely on stringent temperature controls during transportation and storage.

Source: PAHO

The distributors are placing heat, humidity, motion and location sensors on the pallets (or even vaccines themselves) to help researchers monitor the vials of vaccine in real time wherever they are in the world and identify weak links in the supply chain. 

Conclusion

Vaccination has proven to be an effective measure to control infectious diseases, and the rapid emergence of COVID-19 has shown the importance of developing safe and effective vaccines in a minimal time frame.

Big data and the internet of things can help pharmaceutical companies anticipate the shortage of production and distribution of the newly developed RNA vaccines.